Sign in
CompletedNo phase

Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis

Key facts

Who runs it
Huashan Hospital
Where
China9 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,032 people enrolled
Started
29 Dec 2021
Ended
29 Dec 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • droplet digital PCR method
  • blood culture
Record updated
11 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • 1.18 years or older
  • 2.Meet 2 of 4 sepsis criteria
  • Temperature > 38C or < 36C
  • Heart rate > 90 bpm
  • Respiratory rate >20 or PaCO2 <32mmHg
  • WBC >12000/µL or < 4000/µL or > 10% bands; 3.Hospitalized patients who have a diagnostic blood culture ordered as standard of care for suspected sepsis; 4.Informed Consent by patient or legal representative

Who cannot take part

  • Refusal to participate in the study or Failure to comply with treatment or follow-up time
  • The researcher believes that there are any conditions (social or medical) that allow subjects to participate is unsafe. For example, severe anemia or high risk of bleeding,etc., which are not suitable for taking peripheral blood for testing
  • Known breastfeeding or pregnancy
  • Participating in other clinical studies

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sepsis is a significant public health concern worldwide, with high morbidity and mortality. With regard to a targeted antimicrobial treatment strategy, the earliest possible pathogen detection is of crucial importance. Until now, culture-based detection methods represent the diagnostic gold standard, although they are characterized by numerous limitations. Culture-independent molecular diagnostic procedures may represent a promising alternative. In particular, droplet digital PCR (ddPCR) is a novel one-step PCR assay that achieves higher accuracy and sensitivity in detecting causing pathogens in patients with bloodstream infections.

The 2 groups in the trial

  • droplet digital PCR methodTreatment being tested

    Pathogen detection by droplet digital PCR method as an adjunct to traditional microbiological assessments including blood culture

  • blood culture onlyExisting treatment, for comparison

    Pathogen detection by microbiological assessments including blood culture

    Treatment: blood culture

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
11 July 2025